Cooper Companies reduced rate to CIBA a positive, says William Blair William Blair notes that Cooper Companies on Friday night announced it had entered an amendment related to its license agreement with CIBA Vision which lowered the royalty rate Cooper pays on each silicone hydrogel product it sells. William Blair estimates that the royalty rate is now 4%-5% for each silicone hydrogel sold, compared with 8% previously, based on Cooper's increased earnings guidance. The firm recommends investors accumulate shares of Cooper Companies at these levels and keeps an Outperform rating on the name.
K2M, Cooper favorite med tech names in current envirnoment, says Piper Jaffray Piper Jaffray analyst Matt O'Brien said that his favorite names in medical technology given the current environment of broader market weakness are K2M Group (KTWO) and Cooper Companies (COO) given their limited exposure to China and the fact that neither has large exposure to big capital equipment purchases or deferrable procedures nor are they in need of capital. O'Brien has Overweight ratings on both stocks.